Mukherjee Pallavi, Hough Greg, Chattopadhyay Arnab, Navab Mohamad, Fogelman Hannah R, Meriwether David, Williams Kevin, Bensinger Steven, Moller Travis, Faull Kym F, Lusis Aldons J, Iruela-Arispe Luisa, Bostrom Kristina I, Tontonoz Peter, Reddy Srinivasa T, Fogelman Alan M   Transgenic Tomatoes Expressing the 6F Peptide and Ezetimibe Prevent Diet-induced Increases of Interferon-β and Cholesterol 25-hydroxylase in Jejunum Journal of lipid research, 2017; .

Reed Robert M, Borgan Saif M, Eberlein Michael, Goldklang Monica, Lewis Joshua, Miller Michael, Navab Mohamad, Kim Bo S   Tobacco Smoke Exposure Reduces Paraoxonase Activity in a Murine Model International journal of biomedical science : IJBS, 2017; 13(1): 20-25.

Li Rongsong, Yang Jieping, Saffari Arian, Jacobs Jonathan, Baek Kyung In, Hough Greg, Larauche Muriel H, Ma Jianguo, Jen Nelson, Moussaoui Nabila, Zhou Bill, Kang Hanul, Reddy Srinivasa, Henning Susanne M, Campen Matthew J, Pisegna Joseph, Li Zhaoping, Fogelman Alan M, Sioutas Constantinos, Navab Mohamad, Hsiai Tzung K   Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites Scientific reports, 2017; 7(1): 42906.

Mehta Niyati U, Grijalva Victor, Hama Susan, Wagner Alan, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function Arteriosclerosis, thrombosis, and vascular biology, 2016; 36(6): 1152-63.

Chattopadhyay Arnab, Navab Mohamad, Hough Greg, Grijalva Victor, Mukherjee Pallavi, Fogelman Hannah R, Hwang Lin H, Faull Kym F, Lusis Aldons J, Reddy Srinivasa T, Fogelman Alan M   Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD Journal of lipid research, 2016; 57(5): 832-47.

Nguyen Su Duy, Maaninka Katariina, Lappalainen Jani, Nurmi Katariina, Metso Jari, Öörni Katariina, Navab Mohamad, Fogelman Alan M, Jauhiainen Matti, Lee-Rueckert Miriam, Kovanen Petri T   Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties Arteriosclerosis, thrombosis, and vascular biology, 2016; 36(2): 274-84.

Ross David J, Hough Greg, Hama Susan, Aboulhosn Jamil, Belperio John A, Saggar Rajan, Van Lenten Brian J, Ardehali Abbas, Eghbali Mansoureh, Reddy Srinivasa, Fogelman Alan M, Navab Mohamad   Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension Pulmonary circulation, 2015; 5(4): 640-8.

Briot Anaïs, Civelek Mete, Seki Atsuko, Hoi Karen, Mack Julia J, Lee Stephen D, Kim Jason, Hong Cynthia, Yu Jingjing, Fishbein Gregory A, Vakili Ladan, Fogelman Alan M, Fishbein Michael C, Lusis Aldons J, Tontonoz Peter, Navab Mohamad, Berliner Judith A, Iruela-Arispe M Luisa   Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis The Journal of experimental medicine, 2015; 212(12): 2147-63.

Chattopadhyay Arnab, Grijalva Victor, Hough Greg, Su Feng, Mukherjee Pallavi, Farias-Eisner Robin, Anantharamaiah G M, Faull Kym F, Hwang Lin H, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer Pharmacology research & perspectives, 2015; 3(4): e00154.

Micewicz Ewa D, Bahattab Omar S O, Willars Gary B, Waring Alan J, Navab Mohamad, Whitelegge Julian P, McBride William H, Ruchala Piotr   Small lipidated anti-obesity compounds derived from neuromedin U European journal of medicinal chemistry, 2015; 101(12): 616-26.

Nguyen Su Duy, Javanainen Matti, Rissanen Sami, Zhao Hongxia, Huusko Jenni, Kivelä Annukka M, Ylä-Herttuala Seppo, Navab Mohamad, Fogelman Alan M, Vattulainen Ilpo, Kovanen Petri T, Öörni Katariina   Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation Journal of lipid research, 2015; 56(6): 1206-21.

Navab Mohamad, Chattopadhyay Arnab, Hough Greg, Meriwether David, Fogelman Spencer I, Wagner Alan C, Grijalva Victor, Su Feng, Anantharamaiah G M, Hwang Lin H, Faull Kym F, Reddy Srinivasa T, Fogelman Alan M   Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis Journal of lipid research, 2015; 56(4): 871-87.

Jiang Hui, Yazdanyar Amirfarbod, Lou Bin, Chen Yunqin, Zhao Xiaomin, Li Ruohan, Hoang Bui Hai, Kuo Ming-Shang, Navab Mohamad, Qin Shucun, Li Zhiqiang, Jin Weijun, Jiang Xian-Cheng   Adipocyte phospholipid transfer protein and lipoprotein metabolism Arteriosclerosis, thrombosis, and vascular biology, 2015; 35(2): 316-22.

Sharma Salil, Umar Soban, Potus Francois, Iorga Andrea, Wong Gabriel, Meriwether David, Breuils-Bonnet Sandra, Mai Denise, Navab Kaveh, Ross David, Navab Mohamad, Provencher Steeve, Fogelman Alan M, Bonnet Sébastien, Reddy Srinivasa T, Eghbali Mansoureh   Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p Circulation, 2014; 130(9): 776-85.

Reddy Srinivasa T, Navab Mohamad, Anantharamaiah Gattadahalli M, Fogelman Alan M   Apolipoprotein A-I mimetics Current opinion in lipidology, 2014; 25(4): 304-8.

Reddy Srinivasa T, Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   Searching for a successful HDL-based treatment strategy Biochimica et biophysica acta, 2014; 1841(1): 162-7.

Kim Juyong Brian, Hama Susan, Hough Greg, Navab Mohamad, Fogelman Alan M, Maclellan W Robb, Horwich Tamara B, Fonarow Gregg C   Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins The American journal of cardiology, 2013; 112(11): 1770-7.

Fogelman Alan M, Reddy Srinivasa T, Navab Mohamad   Protection against ischemia/reperfusion injury by high-density lipoprotein and its components Circulation research, 2013; 113(12): 1281-2.

Navab Mohamad, Hough Greg, Buga Georgette M, Su Feng, Wagner Alan C, Meriwether David, Chattopadhyay Arnab, Gao Feng, Grijalva Victor, Danciger Janet S, Van Lenten Brian J, Org Elin, Lusis Aldons J, Pan Calvin, Anantharamaiah G M, Farias-Eisner Robin, Smyth Susan S, Reddy Srinivasa T, Fogelman Alan M   Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid Journal of lipid research, 2013; 54(12): 3403-18.

Reddy Srinivasa T, Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   Searching for a Successful HDL-based Treatment Strategy Biochimica et biophysica acta, 2013; 54(12): 3403-18.

Du Yunfeng, Navab Mohamad, Shen Melody, Hill James, Pakbin Payam, Sioutas Constantinos, Hsiai Tzung K, Li Rongsong   Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS Biochemical and biophysical research communications, 2013; 436(3): 462-6.

Li Rongsong, Navab Mohamad, Pakbin Payam, Ning Zhi, Navab Kaveh, Hough Greg, Morgan Todd E, Finch Caleb E, Araujo Jesus A, Fogelman Alan M, Sioutas Constantinos, Hsiai Tzung   Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice Journal of lipid research, 2013; 54(6): 1608-15.

Yin Fen, Lawal Akeem, Ricks Jerry, Fox Julie R, Larson Tim, Navab Mohamad, Fogelman Alan M, Rosenfeld Michael E, Araujo Jesus A   Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein Arteriosclerosis, thrombosis, and vascular biology, 2013; 33(6): 1153-61.

Chattopadhyay Arnab, Navab Mohamad, Hough Greg, Gao Feng, Meriwether David, Grijalva Victor, Springstead James R, Palgunachari Mayakonda N, Namiri-Kalantari Ryan, Su Feng, Van Lenten Brian J, Wagner Alan C, Anantharamaiah G M, Farias-Eisner Robin, Reddy Srinivasa T, Fogelman Alan M   A Novel Approach to Oral ApoA-I Mimetic Therapy Journal of lipid research, 2013; .

Navab Mohamad, Shabihkhani Maryam, Navab Kaveh Daniel, Vazirian Samra, Haghnegahdar Maryam, Reddy Srinivasa T   Reducing plasma cholesterol is not the end of the quest Atherosclerosis, 2013; .

Li Rongsong, Mittelstein David, Kam Winnie, Pakbin Payam, Du Yunfeng, Tintut Yin, Navab Mohamad, Sioutas Constantinos, Hsiai Tzung   Atmospheric Ultrafine Particles Promote Vascular Calcification via the NF-?B Signaling Pathway American journal of physiology. Cell physiology, 2012; .

Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Buga Georgette M, Hough Greg, Wagner Alan C, Fogelman Alan M   High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature Arteriosclerosis, thrombosis, and vascular biology, 2012; 32(11): 2553-60.

Gao Feng, Chattopadhyay Arnab, Navab Mohamad, Grijalva Victor, Su Feng, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1? in human ovarian cancer cell lines and a mouse ovarian cancer model The Journal of pharmacology and experimental therapeutics, 2012; 342(2): 255-62.

Kelesidis Theodoros, Reddy Srinivasa T, Huynh Diana, Meriwether David, Fogelman Alan M, Navab Mohamad, Yang Otto O   Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity Lipids in health and disease, 2012; 11(2): 87.

Su Feng, Grijalva Victor, Navab Kaveh, Ganapathy Ekambaram, Meriwether David, Imaizumi Satoshi, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer Molecular cancer therapeutics, 2012; 11(6): 1311-9.

Ganapathy Ekambaram, Su Feng, Meriwether David, Devarajan Asokan, Grijalva Victor, Gao Feng, Chattopadhyay Arnab, Anantharamaiah G M, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD International journal of cancer. Journal international du cancer, 2012; 130(5): 1071-81.

Navab Mohamad, Reddy Srinivasa T, Anantharamaiah G M, Hough Greg, Buga Georgette M, Danciger Jan, Fogelman Alan M   D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice Journal of lipid research, 2012; 53(3): 437-45.

Ishikawa Kazunobu, Navab Mohamad, Lusis Aldons J   Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice International journal of hypertension, 2012; 2012(3): 948203.

Kelesidis Theodoros, Currier Judith S, Huynh Diana, Meriwether David, Charles-Schoeman Christina, Reddy Srinivasa T, Fogelman Alan M, Navab Mohamad, Yang Otto O   A biochemical fluorometric method for assessing the oxidative properties of HDL Journal of lipid research, 2011; 52(12): 2341-51.

Morgantini Cecilia, Natali Andrea, Boldrini Beatrice, Imaizumi Satoshi, Navab Mohamad, Fogelman Alan M, Ferrannini Ele, Reddy Srinivasa T   Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Diabetes, 2011; 60(10): 2617-23.

Meriwether David, Imaizumi Satoshi, Grijalva Victor, Hough Greg, Vakili Ladan, Anantharamaiah G M, Farias-Eisner Robin, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Shechter Ishaiahu   Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma Journal of lipid research, 2011; 52(10): 1795-809.

Navab Mohamad, Reddy Srinivasa T, Anantharamaiah G M, Imaizumi Satoshi, Hough Greg, Hama Susan, Fogelman Alan M   Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally Journal of lipid research, 2011; 52(6): 1200-10.

Vaziri Nosratola D, Navab Kaveh, Gollapudi Pavan, Moradi Hamid, Pahl Madeleine V, Barton Cyril H, Fogelman Alan M, Navab Mohamad   Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease Journal of the National Medical Association, 2011; 103(6): 524-33.

Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nature reviews. Cardiology, 2011; 8(4): 222-32.

Kelesidis Theodoros, Yang Otto O, Currier Judith S, Navab Kaveh, Fogelman Alan M, Navab Mohamad   HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL Lipids in health and disease, 2011; 10(4): 35.

Gao Feng, Vasquez Sergio X, Su Feng, Roberts Svetlana, Shah Neha, Grijalva Victor, Imaizumi Satoshi, Chattopadhyay Arnab, Ganapathy Ekambaram, Meriwether David, Johnston Brad, Anantharamaiah G M, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways Integrative biology : quantitative biosciences from nano to macro, 2011; 3(4): 479-89.

Navab Kaveh D, Elboudwarej Omeed, Gharif Mackena, Yu Jeryl, Hama Susan Y, Safarpour Sheila, Hough Greg P, Vakili Ladan, Reddy Srinivasa T, Navab Mohamad, Vaziri Nosratola D   Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease Current pharmaceutical design, 2011; 17(1): 17-20.

Imaizumi Satoshi, Navab Mohamad, Morgantini Cecilia, Charles-Schoeman Christina, Su Feng, Gao Feng, Kwon Murray, Ganapathy Ekambaram, Meriwether David, Farias-Eisner Robin, Fogelman Alan M, Reddy Srinivasa T   Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins Circulation journal : official journal of the Japanese Circulation Society, 2011; 75(7): 1533-8.

Devarajan Asokan, Bourquard Noam, Hama Susan, Navab Mohamad, Grijalva Victor R, Morvardi Susan, Clarke Catherine F, Vergnes Laurent, Reue Karen, Teiber John F, Reddy Srinivasa T   Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis Antioxidants & redox signaling, 2011; 14(3): 341-51.

Watson Catherine E, Weissbach Nicole, Kjems Lise, Ayalasomayajula Surya, Zhang Yiming, Chang Ih, Navab Mohamad, Hama Susan, Hough Greg, Reddy Srinivasa T, Soffer Daniel, Rader Daniel J, Fogelman Alan M, Schecter Alison   Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function Journal of lipid research, 2011; 52(2): 361-73.

Morgantini Cecilia, Imaizumi Satoshi, Grijalva Victor, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes Diabetes, 2010; 59(12): 3223-8.

Vaziri Nosratola D, Kim Hyun Ju, Moradi Hamid, Farmand Farbod, Navab Kaveh, Navab Mohamad, Hama Susan, Fogelman Alan M, Quiroz Yasmir, Rodriguez-Iturbe Bernardo   Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010; 25(11): 3525-34.

Su Feng, Kozak Kathy R, Imaizumi Satoshi, Gao Feng, Amneus Malaika W, Grijalva Victor, Ng Carey, Wagner Alan, Hough Greg, Farias-Eisner Gina, Anantharamaiah G M, Van Lenten Brian J, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer Proceedings of the National Academy of Sciences of the United States of America, 2010; 107(46): 19997-20002.

Imaizumi Satoshi, Grijalva Victor, Priceman Saul, Wu Lily, Su Feng, Farias-Eisner Robin, Hama Susan, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels Molecular genetics and metabolism, 2010; 101(1): 66-75.

Imaizumi Satoshi, Grijalva Victor, Navab Mohamad, Van Lenten Brian J, Wagner Alan C, Anantharamiah G M, Fogelman Alan M, Reddy Srinivasa T   L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice Drug metabolism letters, 2010; 4(3): 139-48.

Imaizumi Satoshi, Grijalva Victor, Navab Mohamad, Van Lenten Brian J, Wagner Alan C, Anantharamiah G M, Fogelman Alan M, Reddy Srinivasa T   L-4F Differentially Alters Plasma Levels of Oxidized Fatty Acids Resulting in More Anti-inflammatory HDL in Mice Drug metabolism letters, 2010; 4(3): .

Vaziri Nosratola D, Navab Mohamad, Fogelman Alan M   HDL metabolism and activity in chronic kidney disease Nature reviews. Nephrology, 2010; 6(5): 287-96.

Ruchala Piotr, Navab Mohamad, Jung Chun-Ling, Hama-Levy Susan, Micewicz Ewa D, Luong Hai, Reyles Jonathan E, Sharma Shantanu, Waring Alan J, Fogelman Alan M, Lehrer Robert I   Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids PloS one, 2010; 5(4): e10181.

Buga Georgette M, Navab Mohamad, Imaizumi Satoshi, Reddy Srinivasa T, Yekta Babak, Hough Greg, Chanslor Shawn, Anantharamaiah G M, Fogelman Alan M   L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation Arteriosclerosis, thrombosis, and vascular biology, 2010; 30(2): 283-9.

Navab Mohamad, Shechter Ishaiahu, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   Structure and function of HDL mimetics Arteriosclerosis, thrombosis, and vascular biology, 2010; 30(2): 164-8.

Vakili Ladan, Hama Susan, Kim J Brian, Tien Duc, Safarpoor Shila, Ly Nancy, Vakili Ghazal, Hough Greg, Navab Mohamad   The effect of HDL mimetic peptide 4F on PON1 Advances in experimental medicine and biology, 2010; 660(2): 167-72.

Woo Jennifer M P, Lin Zhuofeng, Navab Mohamad, Van Dyck Casey, Trejo-Lopez Yvette, Woo Krystal M T, Li Hongyun, Castellani Lawrence W, Wang Xuping, Iikuni Noriko, Rullo Ornella J, Wu Hui, La Cava Antonio, Fogelman Alan M, Lusis Aldons J, Tsao Betty P   Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis Arthritis research & therapy, 2010; 12(3): R93.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   HDL as a biomarker, potential therapeutic target, and therapy Diabetes, 2009; 58(12): 2711-7.

Navab Mohamad, Ruchala Piotr, Waring Alan J, Lehrer Robert I, Hama Susan, Hough Greg, Palgunachari Mayakonda N, Anantharamaiah G M, Fogelman Alan M   A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids Journal of lipid research, 2009; 50(8): 1538-47.

Toumpoulis Ioannis K, Oxford Julia Thom, Cowan Douglas B, Anagnostopoulos Constantine E, Rokkas Chris K, Chamogeorgakis Themistocles P, Angouras Dimitrios C, Shemin Richard J, Navab Mohamad, Ericsson Maria, Federman Micheline, Levitsky Sidney, McCully James D   Differential expression of collagen type V and XI alpha-1 in human ascending thoracic aortic aneurysms The Annals of thoracic surgery, 2009; 88(2): 506-13.

Vaziri Nosratola D, Moradi Hamid, Pahl Madeleine V, Fogelman Alan M, Navab Mohamad   In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide Kidney international, 2009; 76(4): 437-44.

Watanabe Junji, Grijalva Victor, Hama Susan, Barbour Karen, Berger Franklin G, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein The Journal of biological chemistry, 2009; 284(27): 18292-301.

Mahdavi Homa, Kim Juyong Brian, Safarpour Scheila, Tien Duc A, Navab Mohamad   Dyslipidemia and cardiovascular diseases Current opinion in lipidology, 2009; 20(2): 157-8.

Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Anantharamaiah G M, Fogelman Alan M   The role of dysfunctional HDL in atherosclerosis Journal of lipid research, 2009; 50 Suppl(2): S145-9.

Van Lenten Brian J, Wagner Alan C, Anantharamaiah G M, Navab Mohamad, Reddy Srinivasa T, Buga Georgette M, Fogelman Alan M   Apolipoprotein A-I mimetic peptides Current atherosclerosis reports, 2009; 11(1): 52-7.

Van Lenten Brian J, Wagner Alan C, Jung Chun-Ling, Ruchala Piotr, Waring Alan J, Lehrer Robert I, Watson Andrew D, Hama Susan, Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I Journal of lipid research, 2008; 49(11): 2302-11.

Van Lenten Brian J, Navab Mohamad, Anantharamaiah G M, Buga Georgette M, Reddy Srinivasa T, Fogelman Alan M   Multiple indications for anti-inflammatory apolipoprotein mimetic peptides Current opinion in investigational drugs (London, England : 2000), 2008; 9(11): 1157-62.

Cruz Daniel, Watson Andrew D, Miller Christopher S, Montoya Dennis, Ochoa Maria-Teresa, Sieling Peter A, Gutierrez Miguel A, Navab Mohamad, Reddy Srinivasa T, Witztum Joseph L, Fogelman Alan M, Rea Thomas H, Eisenberg David, Berliner Judith, Modlin Robert L   Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy The Journal of clinical investigation, 2008; 118(8): 2917-28.

Navab Mohamad, Gharavi Nima, Watson Andrew D   Inflammation and metabolic disorders Current opinion in clinical nutrition and metabolic care, 2008; 11(4): 459-64.

Bloedon Leanne T, Dunbar Richard, Duffy Danielle, Pinell-Salles Paula, Norris Robert, DeGroot Bruce J, Movva Rajesh, Navab Mohamad, Fogelman Alan M, Rader Daniel J   Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients Journal of lipid research, 2008; 49(6): 1344-52.

Charles-Schoeman Christina, Banquerigo Mona Lisa, Hama Susan, Navab Mohamad, Park Grace S, Van Lenten Brian J, Wagner Alan C, Fogelman Alan M, Brahn Ernest   Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis Clinical immunology (Orlando, Fla.), 2008; 127(2): 234-44.

Yu Roger, Yekta Babak, Vakili Ladan, Gharavi Navid, Navab Mohamad, Marelli Daniel, Ardehali Abbas   Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides Current atherosclerosis reports, 2008; 10(2): 171-6.

Araujo Jesus A, Barajas Berenice, Kleinman Michael, Wang Xuping, Bennett Brian J, Gong Ke Wei, Navab Mohamad, Harkema Jack, Sioutas Constantinos, Lusis Aldons J, Nel Andre E   Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress Circulation research, 2008; 102(5): 589-96.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   Apo A-1 mimetic peptides as atheroprotective agents in murine models Current drug targets, 2008; 9(3): 204-9.

Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis Trends in cardiovascular medicine, 2008; 18(2): 61-6.

Buga Georgette M, Frank Joy S, Mottino Giuliano A, Hakhamian Ashkan, Narasimha Ajay, Watson Andrew D, Yekta Babak, Navab Mohamad, Reddy Srinivasa T, Anantharamaiah G M, Fogelman Alan M   D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet Journal of lipid research, 2008; 49(1): 192-205.

Van Lenten Brian J, Wagner Alan C, Navab Mohamad, Anantharamaiah G M, Hama Susan, Reddy Srinivasa T, Fogelman Alan M   Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits Journal of lipid research, 2007; 48(11): 2344-53.

Navab Mohamad, Yu Roger, Gharavi Nima, Huang William, Ezra Navid, Lotfizadeh Ali, Anantharamaiah G M, Alipour Nima, Van Lenten Brian J, Reddy Srinivasa T, Marelli Daniel   High-density lipoprotein: antioxidant and anti-inflammatory properties Current atherosclerosis reports, 2007; 9(3): 244-8.

Anantharamaiah G M, Mishra Vinod K, Garber David W, Datta Geeta, Handattu Shaila P, Palgunachari Mayakonda N, Chaddha Manjula, Navab Mohamad, Reddy Srinivasa T, Segrest Jere P, Fogelman Alan M   Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Journal of lipid research, 2007; 48(9): 1915-23.

Narasimha Ajay, Watanabe Junji, Lin James A, Hama Susan, Langenbach Robert, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors Prostaglandins & other lipid mediators, 2007; 84(1-2): 24-33.

Watanabe Junji, Chou Katherine J, Liao James C, Miao Yunan, Meng Hsiang-Hui, Ge Helen, Grijalva Victor, Hama Susan, Kozak Kathy, Buga Georgette, Whitelegge Julian P, Lee Terry D, Farias-Eisner Robin, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis The Journal of biological chemistry, 2007; 282(32): 23698-707.

Ng Carey J, Bourquard Noam, Hama Susan Y, Shih Diana, Grijalva Victor R, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice Arteriosclerosis, thrombosis, and vascular biology, 2007; 27(6): 1368-74.

Yu Roger, Navab Mohamad   Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptides Future cardiology, 2007; 3(3): 309-19.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Buga Georgette M, Fogelman Alan M   Peptide Mimetics of Apolipoproteins Improve HDL Function Journal of clinical lipidology, 2007; 1(2): 142-7.

Sanossian Nerses, Saver Jeffrey L, Navab Mohamad, Ovbiagele Bruce   High-density lipoprotein cholesterol: an emerging target for stroke treatment Stroke; a journal of cerebral circulation, 2007; 38(3): 1104-9.

Ansell Benjamin J, Fonarow Gregg C, Navab Mohamad, Fogelman Alan M   Modifying the anti-inflammatory effects of high-density lipoprotein Current atherosclerosis reports, 2007; 9(1): 57-63.

Ng Carey J, Hama Susan Y, Bourquard Noam, Navab Mohamad, Reddy Srinivasa T   Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice Molecular genetics and metabolism, 2006; 89(4): 368-73.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Fogelman Alan M   Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention Nature clinical practice. Cardiovascular medicine, 2006; 3(10): 540-7.

Buga Georgette M, Frank Joy S, Mottino Giuliano A, Hendizadeh Michael, Hakhamian Ashkan, Tillisch Jan H, Reddy Srinivasa T, Navab Mohamad, Anantharamaiah G M, Ignarro Louis J, Fogelman Alan M   D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet Journal of lipid research, 2006; 47(10): 2148-60.

Ng Carey J, Bourquard Noam, Grijalva Victor, Hama Susan, Shih Diana M, Navab Mohamad, Fogelman Alan M, Lusis Aldons J, Young Stephen, Reddy Srinivasa T   Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2 The Journal of biological chemistry, 2006; 281(40): 29491-500.

Navab Mohamad, Anantharamaiah Gattadahalli M, Reddy Srinivasa T, Van Lenten Brian J, Ansell Benjamin J, Fogelman Alan M   Mechanisms of disease: proatherogenic HDL--an evolving field Nature clinical practice. Endocrinology & metabolism, 2006; 2(9): 504-11.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Datta Geeta, Garber David, Fogelman Alan M   Potential clinical utility of high-density lipoprotein-mimetic peptides Current opinion in lipidology, 2006; 17(4): 440-4.

McMahon Maureen, Grossman Jennifer, FitzGerald John, Dahlin-Lee Erika, Wallace Daniel J, Thong Bernard Y, Badsha Humeira, Kalunian Kenneth, Charles Christina, Navab Mohamad, Fogelman Alan M, Hahn Bevra H   Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis Arthritis and rheumatism, 2006; 54(8): 2541-9.

Van Lenten Brian J, Reddy Srinivasa T, Navab Mohamad, Fogelman Alan M   Understanding changes in high density lipoproteins during the acute phase response Arteriosclerosis, thrombosis, and vascular biology, 2006; 26(8): 1687-8.

Anantharamaiah Gm, Navab Mohamad, Reddy Srinivasa T, Garber David W, Datta Geeta, Gupta Himanshu, White C Roger, Handattu Shaila P, Palgunachari Mayakonda N, Chaddha Manjula, Mishra Vinod K, Segrest Jere P, Fogelman Alan M   Synthetic peptides: managing lipid disorders Current opinion in lipidology, 2006; 17(3): 233-7.

Reddy Srinivasa T, Anantharamaiah G M, Navab Mohamad, Hama Susan, Hough Gregory, Grijalva Victor, Garber David W, Datta Geeta, Fogelman Alan M   Oral amphipathic peptides as therapeutic agents Expert opinion on investigational drugs, 2006; 15(1): 13-21.

Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I Circulation research, 2005; 97(11): 1085-6.

Ansell Benjamin J, Watson Karol E, Fogelman Alan M, Navab Mohamad, Fonarow Gregg C   High-density lipoprotein function recent advances Journal of the American College of Cardiology, 2005; 46(10): 1792-8.

Moore Ryan E, Navab Mohamad, Millar John S, Zimetti Francesca, Hama Susan, Rothblat George H, Rader Daniel J   Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation Circulation research, 2005; 97(8): 763-71.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Wagner Alan C, Hama Susan, Hough Greg, Bachini Eugene, Garber David W, Mishra Vinod K, Palgunachari Mayakonda N, Fogelman Alan M   An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice Arteriosclerosis, thrombosis, and vascular biology, 2005; 25(9): 1932-7.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Hama Susan, Hough Greg, Frank Joy S, Grijalva Victor R, Ganesh Vannakambadi K, Mishra Vinod K, Palgunachari Mayakonda N, Fogelman Alan M   Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice Circulation research, 2005; 97(6): 524-32.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Hama Susan, Hough Greg, Grijalva Victor R, Yu Nicholas, Ansell Benjamin J, Datta Geeta, Garber David W, Fogelman Alan M   Apolipoprotein A-I mimetic peptides Arteriosclerosis, thrombosis, and vascular biology, 2005; 25(7): 1325-31.

Navab Mohamad, Anantharamaiah G M, Hama Susan, Hough Greg, Reddy Srinivasa T, Frank Joy S, Garber David W, Handattu Shaila, Fogelman Alan M   D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice Arteriosclerosis, thrombosis, and vascular biology, 2005; 25(7): 1426-32.

Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   The role of high-density lipoprotein in inflammation Trends in cardiovascular medicine, 2005; 15(4): 158-61.

Navab Mohamad, Ananthramaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Ansell Benjamin J, Hama Susan, Hough Greg, Bachini Eugene, Grijalva Victor R, Wagner Alan C, Shaposhnik Zory, Fogelman Alan M   The double jeopardy of HDL Annals of medicine, 2005; 37(3): 173-8.

Ng Carey J, Shih Diana M, Hama Susan Y, Villa Natividad, Navab Mohamad, Reddy Srinivasa T   The paraoxonase gene family and atherosclerosis Free radical biology & medicine, 2005; 38(2): 153-63.

Ansell Benjamin J, Navab Mohamad, Watson Karol E, Fonarow Gregg C, Fogelman Alan M   Anti-inflammatory properties of HDL Reviews in endocrine & metabolic disorders, 2004; 5(4): 351-8.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Datta Geeta, Garber David, Fogelman Alan M   Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal Current opinion in lipidology, 2004; 15(6): 645-9.

Van Lenten Brian J, Wagner Alan C, Navab Mohamad, Anantharamaiah G M, Hui Eric Ka-Wai, Nayak Debi P, Fogelman Alan M   D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes Circulation, 2004; 110(20): 3252-8.

Barter Philip J, Nicholls Stephen, Rye Kerry-Anne, Anantharamaiah G M, Navab Mohamad, Fogelman Alan M   Antiinflammatory properties of HDL Circulation research, 2004; 95(8): 764-72.

Yan Daoguang, Navab Mohamad, Bruce Can, Fogelman Alan M, Jiang Xian-Cheng   PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity Journal of lipid research, 2004; 45(10): 1852-8.

Reddy Srinivasa T, Nguyen Julie T, Grijalva Victor, Hough Greg, Hama Susan, Navab Mohamad, Fogelman Alan M   Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models Arteriosclerosis, thrombosis, and vascular biology, 2004; 24(9): 1676-81.

Datta Geeta, Epand Raquel F, Epand Richard M, Chaddha Manjula, Kirksey Matthew A, Garber David W, Lund-Katz Sissel, Phillips Michael C, Hama Susan, Navab Mohamad, Fogelman Alan M, Palgunachari Mayakonda N, Segrest Jere P, Anantharamaiah G M   Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity The Journal of biological chemistry, 2004; 279(25): 26509-17.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Hama Susan, Hough Greg, Grijalva Victor R, Wagner Alan C, Frank Joy S, Datta Geeta, Garber David, Fogelman Alan M   Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice Circulation, 2004; 109(25): 3215-20.

Navab Mohamad, Ananthramaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Ansell Benjamin J, Fonarow Gregg C, Vahabzadeh Kambiz, Hama Susan, Hough Greg, Kamranpour Naeimeh, Berliner Judith A, Lusis Aldons J, Fogelman Alan M   The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL Journal of lipid research, 2004; 45(6): 993-1007.

Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a) Arteriosclerosis, thrombosis, and vascular biology, 2004; 24(3): 392-3.

Hsiai Tzung K, Cho Sung K, Wong Pak K, Ing Michael H, Salazar Adler, Hama Susan, Navab Mohamad, Demer Linda L, Ho Chih-Ming   Micro sensors: linking real-time oscillatory shear stress with vascular inflammatory responses Annals of biomedical engineering, 2004; 32(2): 189-201.

Ansell Benjamin J, Navab Mohamad, Hama Susan, Kamranpour Naeimeh, Fonarow Gregg, Hough Greg, Rahmani Shirin, Mottahedeh Rachel, Dave Ravi, Reddy Srinivasa T, Fogelman Alan M   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation, 2003; 108(22): 2751-6.

Hwang Juliana, Ing Michael H, Salazar Adler, Lassègue Bernard, Griendling Kathy, Navab Mohamad, Sevanian Alex, Hsiai Tzung K   Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation Circulation research, 2003; 93(12): 1225-32.

Naghavi Morteza, Libby Peter, Falk Erling, Casscells S Ward, Litovsky Silvio, Rumberger John, Badimon Juan Jose, Stefanadis Christodoulos, Moreno Pedro, Pasterkamp Gerard, Fayad Zahi, Stone Peter H, Waxman Sergio, Raggi Paolo, Madjid Mohammad, Zarrabi Alireza, Burke Allen, Yuan Chun, Fitzgerald Peter J, Siscovick David S, de Korte Chris L, Aikawa Masanori, Juhani Airaksinen K E, Assmann Gerd, Becker Christoph R, Chesebro James H, Farb Andrew, Galis Zorina S, Jackson Chris, Jang Ik-Kyung, Koenig Wolfgang, Lodder Robert A, March Keith, Demirovic Jasenka, Navab Mohamad, Priori Silvia G, Rekhter Mark D, Bahr Raymond, Grundy Scott M, Mehran Roxana, Colombo Antonio, Boerwinkle Eric, Ballantyne Christie, Insull William, Schwartz Robert S, Vogel Robert, Serruys Patrick W, Hansson Goran K, Faxon David P, Kaul Sanjay, Drexler Helmut, Greenland Philip, Muller James E, Virmani Renu, Ridker Paul M, Zipes Douglas P, Shah Prediman K, Willerson James T   From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I Circulation, 2003; 108(14): 1664-72.

Naghavi Morteza, Libby Peter, Falk Erling, Casscells S Ward, Litovsky Silvio, Rumberger John, Badimon Juan Jose, Stefanadis Christodoulos, Moreno Pedro, Pasterkamp Gerard, Fayad Zahi, Stone Peter H, Waxman Sergio, Raggi Paolo, Madjid Mohammad, Zarrabi Alireza, Burke Allen, Yuan Chun, Fitzgerald Peter J, Siscovick David S, de Korte Chris L, Aikawa Masanori, Airaksinen K E Juhani, Assmann Gerd, Becker Christoph R, Chesebro James H, Farb Andrew, Galis Zorina S, Jackson Chris, Jang Ik-Kyung, Koenig Wolfgang, Lodder Robert A, March Keith, Demirovic Jasenka, Navab Mohamad, Priori Silvia G, Rekhter Mark D, Bahr Raymond, Grundy Scott M, Mehran Roxana, Colombo Antonio, Boerwinkle Eric, Ballantyne Christie, Insull William, Schwartz Robert S, Vogel Robert, Serruys Patrick W, Hansson Goran K, Faxon David P, Kaul Sanjay, Drexler Helmut, Greenland Philip, Muller James E, Virmani Renu, Ridker Paul M, Zipes Douglas P, Shah Prediman K, Willerson James T   From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II Circulation, 2003; 108(15): 1772-8.

Navab Mohamad, Hama Susan, Hough Greg, Fogelman Alan M   Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice Circulation, 2003; 108(14): 1735-9.

Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Hough Greg, Wagner Alan, Nakamura Kenta, Garber David W, Datta Geeta, Segrest Jere P, Hama Susan, Fogelman Alan M   Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis Current opinion in investigational drugs (London, England : 2000), 2003; 4(9): 1100-4.